BR112018010679A2 - métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina - Google Patents
métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcinaInfo
- Publication number
- BR112018010679A2 BR112018010679A2 BR112018010679A BR112018010679A BR112018010679A2 BR 112018010679 A2 BR112018010679 A2 BR 112018010679A2 BR 112018010679 A BR112018010679 A BR 112018010679A BR 112018010679 A BR112018010679 A BR 112018010679A BR 112018010679 A2 BR112018010679 A2 BR 112018010679A2
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- treating
- preventing
- virus infection
- diarrhea virus
- Prior art date
Links
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 241000282887 Suidae Species 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000002238 attenuated effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 229940031626 subunit vaccine Drugs 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus
- G01N2333/17—Porcine transmissible gastroenteritis virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Communicable Diseases (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
a presente invenção se refere a imunógenos, composições e métodos para tratar, prevenir e/ou diagnosticar infecção por pedv em porcos. as composições e métodos usam vacinas contendo vírus inativado ou atenuado, ou vacinas de subunidade, incluindo imunógenos e misturas de imunógenos derivados de isolados de pedv.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562260128P | 2015-11-25 | 2015-11-25 | |
US201662382395P | 2016-09-01 | 2016-09-01 | |
PCT/CA2016/051381 WO2017088060A1 (en) | 2015-11-25 | 2016-11-24 | Methods for treating, preventing and diagnosing porcine epidemic diarrhea virus infection |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112018010679A2 true BR112018010679A2 (pt) | 2018-11-13 |
BR112018010679A8 BR112018010679A8 (pt) | 2019-02-26 |
Family
ID=58762804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018010679A BR112018010679A8 (pt) | 2015-11-25 | 2016-11-24 | métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina |
Country Status (9)
Country | Link |
---|---|
US (1) | US20180344836A1 (pt) |
EP (1) | EP3380494A4 (pt) |
BR (1) | BR112018010679A8 (pt) |
CA (1) | CA3004931A1 (pt) |
HK (1) | HK1259323A1 (pt) |
MX (1) | MX2018006416A (pt) |
RU (1) | RU2018123005A (pt) |
TW (1) | TW201731525A (pt) |
WO (1) | WO2017088060A1 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108486067B (zh) * | 2018-02-11 | 2022-03-15 | 黑龙江正康生物技术股份有限公司 | 猪流行性腹泻病毒变异株及其制备的灭活疫苗和应用 |
CN109337876A (zh) * | 2018-10-15 | 2019-02-15 | 北京世纪元亨动物防疫技术有限公司 | 一种猪流行性腹泻病毒的纯化方法 |
MX2021010348A (es) * | 2019-02-28 | 2022-01-06 | Univ Saskatchewan | Composiciones de lawsonia intracellularis y metodos de uso de las mismas. |
CN111474346B (zh) * | 2020-04-15 | 2023-07-11 | 浙江理工大学绍兴生物医药研究院有限公司 | 猪流行性腹泻病毒IgA和IgG抗体检测试剂盒及其制备方法和应用 |
CN112415207B (zh) * | 2020-10-27 | 2022-04-12 | 中国农业科学院兰州兽医研究所 | 一种基于抗猪流行性腹泻病毒变异毒株重组S2蛋白的IgA抗体ELISA检测试剂盒 |
US11879006B2 (en) * | 2021-07-08 | 2024-01-23 | Academia Sinica | Recombinant antibody and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0920240B8 (pt) * | 2008-10-16 | 2021-05-25 | Univ Dalhousie | composição adjuvante |
CN103675274B (zh) * | 2013-12-17 | 2016-03-30 | 广西大学 | 检测猪流行性腹泻病毒抗体的间接elisa试剂盒 |
EP3125932A1 (en) * | 2014-04-03 | 2017-02-08 | Boehringer Ingelheim Vetmedica, Inc. | Porcine epidemic diarrhea virus vaccine |
US9713639B2 (en) * | 2014-05-19 | 2017-07-25 | Merial, Inc. | Recombinant spike protein subunit based vaccine for porcine epidemic diarrhea virus (PEDV) |
DK3166634T3 (da) * | 2014-07-11 | 2021-09-27 | Zoetis Services Llc | Nye vaccinesammensætninger til epidemisk svine-diarrévirus |
CN104262488B (zh) * | 2014-09-24 | 2017-07-28 | 普莱柯生物工程股份有限公司 | 一种融合蛋白及其疫苗组合物的制备与应用 |
-
2016
- 2016-11-23 TW TW105138483A patent/TW201731525A/zh unknown
- 2016-11-24 EP EP16867490.1A patent/EP3380494A4/en not_active Withdrawn
- 2016-11-24 BR BR112018010679A patent/BR112018010679A8/pt not_active IP Right Cessation
- 2016-11-24 CA CA3004931A patent/CA3004931A1/en not_active Abandoned
- 2016-11-24 US US15/779,509 patent/US20180344836A1/en not_active Abandoned
- 2016-11-24 WO PCT/CA2016/051381 patent/WO2017088060A1/en active Application Filing
- 2016-11-24 RU RU2018123005A patent/RU2018123005A/ru not_active Application Discontinuation
- 2016-11-24 MX MX2018006416A patent/MX2018006416A/es unknown
-
2019
- 2019-01-30 HK HK19101689.3A patent/HK1259323A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US20180344836A1 (en) | 2018-12-06 |
BR112018010679A8 (pt) | 2019-02-26 |
MX2018006416A (es) | 2018-11-09 |
EP3380494A1 (en) | 2018-10-03 |
TW201731525A (zh) | 2017-09-16 |
WO2017088060A1 (en) | 2017-06-01 |
HK1259323A1 (zh) | 2019-11-29 |
EP3380494A4 (en) | 2019-11-13 |
RU2018123005A (ru) | 2019-12-25 |
CA3004931A1 (en) | 2017-06-01 |
RU2018123005A3 (pt) | 2020-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112018010679A2 (pt) | métodos para tratar, prevenir e diagnosticar a infecção por vírus da diarréia epidêmica porcina | |
MX2016012845A (es) | Vacuna contra el virus de la diarrea epidemica porcina. | |
BR112018013387A2 (pt) | vetor de vacinação recombinante, vírus mva, vacina ou composição farmacêutica e kit | |
MX2016016722A (es) | Coronavirus. | |
PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
EA201692467A1 (ru) | Вакцины против вируса гриппа и их применения | |
EA201692541A1 (ru) | Вакцины против вируса гриппа и их применения | |
PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
BR112018075440A2 (pt) | composições e métodos para prevenir e tratar a infecção por zika vírus | |
CO6551750A2 (es) | Vacuna del virus del dengue inactivado que incluye un adyuvante sin aluminio | |
BR112019003126A2 (pt) | método de tratamento ou prevenção de diarreia epidêmica suína, vacina e kit de vacinas | |
MX2016016746A (es) | Composiciones de vacuna con adyuvante dual, preparacion y usos. | |
MY179251A (en) | Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development | |
BR112017002440A2 (pt) | vírus da diarreia epizoótica porcina mutante para utilização em uma vacina | |
MX2019007252A (es) | Metodos y composiciones para vacunas del virus del dengue. | |
PH12018501750A1 (en) | Porcine reproductive and respiratory syndrome vaccine virus | |
BR112018074910A2 (pt) | composição imunológica, e, método de indução de uma resposta imunológica contra o vírus da influenza equina em um sujeito | |
BR112016015078A2 (pt) | método para prevenir ou tratar infecção por vírus influenza a h7n9, uso do anticorpo e composição farmacêutica | |
PH12017550047B1 (en) | Use of taurine in prevention and/or treatment of diseases induced by viruses of genus coronavirus and/or genus rotavirus | |
MX2017015004A (es) | Estrategia de vacuna basada en nanoparticulas contra el virus de la influenza porcina. | |
BR112016012393A2 (pt) | Vacina, e, uso de uma combinação de um vírus prrs atenuado vivo e um antígeno de lawsonia intracellularis inativado | |
PH12017501943B1 (en) | Influenza virus neutralizing peptidomimetic compounds | |
MX350283B (es) | Virus recombinantes de influenza porcina y usos del mismo. | |
EA202090236A1 (ru) | Иммуногенные композиции senecavirus a и способы с ними | |
MX2019013779A (es) | Vacuna que comprende toxoides de clostridium. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2647 DE 28/09/2021. |